##gff-version 3
##sequence-region O60443 1 496
O60443	UniProtKB	Chain	1	496	.	.	.	ID=PRO_0000148178;Note=Gasdermin-E	
O60443	UniProtKB	Chain	1	270	.	.	.	ID=PRO_0000442786;Note=Gasdermin-E%2C N-terminal;Ontology_term=ECO:0000269,ECO:0000305;evidence=ECO:0000269|PubMed:27281216,ECO:0000305|PubMed:28459430;Dbxref=PMID:27281216,PMID:28459430	
O60443	UniProtKB	Chain	271	496	.	.	.	ID=PRO_0000442787;Note=Gasdermin-E%2C C-terminal;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:28459430;Dbxref=PMID:28459430	
O60443	UniProtKB	Region	1	56	.	.	.	Note=Membrane targeting domain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28045099;Dbxref=PMID:28045099	
O60443	UniProtKB	Site	270	271	.	.	.	Note=Cleavage%3B by CASP3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28459430;Dbxref=PMID:28459430	
O60443	UniProtKB	Alternative sequence	1	395	.	.	.	ID=VSP_004190;Note=In isoform 2. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|Ref.2,ECO:0000303|Ref.3	
O60443	UniProtKB	Alternative sequence	1	164	.	.	.	ID=VSP_044276;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
O60443	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_030824;Note=P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12690205;Dbxref=dbSNP:rs754554,PMID:12690205	
O60443	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_053102;Note=M->T;Dbxref=dbSNP:rs876306	
O60443	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_030825;Note=V->M;Dbxref=dbSNP:rs12540919	
O60443	UniProtKB	Mutagenesis	2	2	.	.	.	Note=No effect on plasma membrane targeting. Decreases induction of necrotic activity. Disrupts plasma membrane targeting and induction of necrotic activity%3B when associated with A-40. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28045099;Dbxref=PMID:28045099	
O60443	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Disrupts plasma membrane targeting and induction of necrotic activity%3B when associated with A-40 and/or A-41. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28045099;Dbxref=PMID:28045099	
O60443	UniProtKB	Mutagenesis	40	40	.	.	.	Note=No effect on plasma membrane targeting. No effect on induction of cytotoxivity. Disrupts plasma membrane targeting and induction of necrotic activity%3B when associated with A-2 or A-39 and A-41. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28045099;Dbxref=PMID:28045099	
O60443	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Disrupts plasma membrane targeting and induction of necrotic activity%3B when associated with A-39 and/or A-41. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28045099;Dbxref=PMID:28045099	
O60443	UniProtKB	Mutagenesis	267	267	.	.	.	Note=Abolishes cleavage by CASP3. Abolishes pyroptosis induction. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28459430;Dbxref=PMID:28459430	
O60443	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Abolishes cleavage by CASP3. Abolishes pyroptosis induction. D->A%2CE;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:28045099,ECO:0000269|PubMed:28459430;Dbxref=PMID:28045099,PMID:28459430	
O60443	UniProtKB	Mutagenesis	313	313	.	.	.	Note=No spontaneous pyroptosis-inducing activity. I->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281216;Dbxref=PMID:27281216	
O60443	UniProtKB	Mutagenesis	388	388	.	.	.	Note=Low spontaneous pyroptosis-inducing activity. F->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281216;Dbxref=PMID:27281216	
O60443	UniProtKB	Mutagenesis	392	392	.	.	.	Note=Low spontaneous pyroptosis-inducing activity. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281216;Dbxref=PMID:27281216	
